- Nextleaf Solutions (CSE:OILS) reported its fourth consecutive profitable quarter with C$2.91M in net revenue and a 25 per cent year-over-year increase in gross profit
- The company launched 11 new products under Glacial Gold and maintained a strong balance sheet with no secured debt and C$5.6M in working capital
- Q4 Plans include launching Canada’s first 200-count softgel format, upgrading vape hardware, expanding operations, and boosting retail engagement through national sampling and events
- Nextleaf stock (CSE:OILS) opened trading at $0.06
Nextleaf Solutions (CSE:OILS) announced its financial results for the third quarter of fiscal year 2025, ended June 30, 2025. The licensed cannabis processor continues its upward trajectory, marking its fourth consecutive profitable quarter without normalization.
This content has been prepared as part of a partnership with Nextleaf Solutions Ltd. and is intended for informational purposes only.
Financial highlights
- Gross revenue: C$3.77 million
- Net revenue: C$2.91 million
- Gross profit: C$1.11 million, a 25 per cent increase year-over-year
- Net income YTD: C$867,352, up 172 per cent from a loss of C$1.2 million in FY24
- Positive EBITDA YTD: C$1.11 million, reflecting strong operational efficiency
Despite competitive pressures in saturated categories such as high-THC vapes and infused prerolls, Nextleaf maintained profitability through strategic SKU rationalization, pricing adjustments, and brand innovation. The company remains on track to exceed FY24 benchmarks in revenue, net income, and adjusted EBITDA.
Balance sheet strength
- Total assets: C$9.0 million
- Working capital: C$5.6 million, up 24 per cent from September 2024
- Debt-to-equity ratio: Reduced to 0.61
- Secured debt: None, reinforcing a strong equity position
Commercial expansion
Nextleaf launched 11 new products under its flagship brand, Glacial Gold, including:
- 3 softgels
- 5 vapes
- 3 bottled oils
These products are distributed nationally and cater to the growing demand for wellness-forward formats such as full-spectrum extracts, ratio-based formulations, and minor cannabinoids like CBG and CBN.
CEO commentary
“In Q3, we rapidly refined our CPG strategy-balancing both offense and defense-to protect and grow revenue from our branded portfolio, accelerate momentum in the categories we lead, and build a foothold where we’ve underperformed or are just entering,” Nextleaf’s CEO, Emma Andrews said in a news release. “We’ve stayed humble, agile, and innovative under pressure, and I look forward to sharing the results of these efforts in the quarters ahead-the numbers will speak for themselves.”
Q4 FY2025 priorities
- Softgel innovation: Launching Canada’s first 200-count format with two SKUs
- Vape technology: Investing in next-gen “post-less” hardware
- Operational expansion: Soft-opening of Nextleaf Distribution site
- Retail engagement: National sampling program distributing 20,000 softgels
- Brand visibility: Hosting experiential events to deepen retail relationships
Nextleaf Solutions develops a range of multi-patented, highly automated, closed-loop extraction and distillation technology that sets the global standard for processing cannabis at-scale.
Nextleaf stock (CSE:OILS) opened trading 7.14 per cent lower at $0.06 and though it is up 30.00 per cent since June, it has lost 23.53 per cent since this time last year.
Join the discussion: Find out what the Bullboards are saying about Nextleaf Solutions and check out Stockhouse’s stock forums and message boards.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.